Russia’s Sputnik V vaccine 91.6% effective against COVID-19 in late-stage trial: study
Russia’s Sputnik V vaccine was 91.6% effective against COVID-19 disease in a late-stage trial, according to new interim results. The...
Full Article
Russia’s Sputnik V vaccine 91.6% effective against COVID-19 in late-stage trial: study
Upworthy
0 shares
4 views
You might like
Related news coverage
Novavax Vaccine Trial Gets 30,000 Volunteers
Newsy
Watch VideoNovavax has about 30,000 volunteers from the U.S. and Mexico for its COVID vaccine candidate.
The company is..
The (Non-)Success Story Of Sputnik-V Vaccine – OpEd
Eurasia Review
-
Italy teachers balk at AstraZeneca vaccine plans
SeattlePI.com
-
EU's top diplomat hopes Sputnik V will be approved in bloc
SeattlePI.com
Advertisement
More coverage
Russia's Sputnik V COVID vaccine 91.6% effective with two doses, tests show
Sky News
Russia's Sputnik V vaccine is 91.6% effective against coronavirus when two doses are given, according to peer-reviewed interim..
-
Russia's Sputnik V vaccine has 'high efficacy' of 91.6 per cent, according to Lancet study
SBS
-
Study: Russia's Sputnik V vaccine appears safe, effective
Haaretz
-
Russia’s Sputnik Vaccine Safe, Effective Against COVID-19, Study Finds
VOA News
-
Study: Russia's Sputnik V vaccine appears safe, effective
SeattlePI.com